Profil
David Edgren is currently the Chief Scientific Officer at SinuSys Corp.
He previously worked as a Principal at ALZA Corp.
and as a Principal Investigator at XenoPort, Inc. Mr. Edgren received his undergraduate degree from the University of California, Santa Barbara.
Postes actifs de David Edgren
| Sociétés | Poste | Début |
|---|---|---|
SinuSys Corp.
SinuSys Corp. Medical SpecialtiesHealth Technology Develops medical device therapies to improve the sinus health of patients with chronic sinusitis | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de David Edgren
| Sociétés | Poste | Fin |
|---|---|---|
| ALZA CORPORATION | Corporate Officer/Principal | - |
| XENOPORT, INC. | Corporate Officer/Principal | - |
Formation de David Edgren
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
ALZA Corp.
ALZA Corp. Pharmaceuticals: MajorHealth Technology Provides and develops pharmaceutical products | Health Technology |
XenoPort, Inc.
XenoPort, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing of pharmaceutical products for the potential treatment of neurological disorders | Health Technology |
University of California, Santa Barbara
University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SinuSys Corp.
SinuSys Corp. Medical SpecialtiesHealth Technology Develops medical device therapies to improve the sinus health of patients with chronic sinusitis | Health Technology |
















